Cartesian Therapeutics, Inc. (RNAC) quarterly cash flow statement — complete operating, investing & financing history
Cartesian Therapeutics, Inc. (RNAC) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -27.73M | -20.63M | -22.14M | -17.71M | -15.6M | -17.52M | -23.11M | -7M | 13.69M | -14.45M | -15.92M | -23.29M | -9.21M | -9.89M | -8.77M | -11.85M | 4.35M | -12.27M | -11.86M | -31.46M |
| Operating CF Margin % | - | - | -28378.21% | -1870.33% | -3451.33% | -5879.53% | -2100.73% | 922.53% | 3537.73% | -43.19% | -272.55% | -281.71% | -140.67% | -188.51% | -147.61% | -70.55% | 21.02% | -31.25% | -34.9% | -105.09% |
| Operating CF Growth % | -77.77% | -17.72% | 4.21% | -152.96% | -213.94% | -21.29% | -45.18% | 69.93% | 248.57% | -45.99% | -81.6% | -96.52% | -311.69% | 19.36% | 26.12% | 62.34% | 140.51% | -103.06% | 2.22% | -333.93% |
| Net Income | -11.47M | 15.77M | -39.18M | -92.58M | -35.9M | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M |
| Depreciation & Amortization | 1.03M | 779K | 615K | 608K | 606K | 589K | 1.16M | 486K | 286K | 196K | 183K | 272K | 189K | 176K | 206K | 241K | 350K | 345K | 351K | 401K |
| Stock-Based Compensation | 0 | 2.08M | 2.42M | 2.14M | 2.59M | 3.28M | 2.51M | 1.86M | 1.7M | 1.59M | 1.43M | 17.4M | 2.32M | 3.78M | 2.28M | 2.28M | 2.6M | 3.56M | 2.75M | 2.25M |
| Deferred Taxes | 0 | 0 | 0 | -9.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.34M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -10.7M | -39.65M | 13.94M | 81.31M | 16.58M | -35.77M | -1.98M | -5.95M | 10.08M | 2.01M | 45.66M | 141.14M | -2.69M | 561K | 4.81M | -13.22M | 6.95M | 5.14M | -17.98M | -8.48M |
| Working Capital Changes | -6.59M | 388K | 68K | -3K | 530K | -1.51M | -7.08M | 6.85M | 25.81M | -32.08M | -6.37M | -4.44M | -34K | 3.31M | 5.6M | -7.04M | 2.35M | -29.92M | -25.76M | -37.88M |
| Change in Receivables | 144K | 65K | 854K | -393K | -368K | 1.41M | -893K | 4.94M | 29.7M | -31.14M | 4.47M | -2.08M | -333K | 1.45M | 1.08M | -2.83M | 17.07M | -16.84M | 2.76M | -2.59M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.31M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -720K | -773K | 310K | -933K | 1.77M | -1.59M | 1.82M | -237K | -2.4M | 343K | -633K | 0 | 85K | -796K | 747K | 102K | -310K | 282K | 18K | -1.37M |
| Cash from Investing | -441K | -272K | -27K | -492K | -1.29M | -2.6M | -1.07M | -354K | -6.2M | -1.59M | -602K | 6.5M | 0 | -12K | 28.12M | 5.49M | -29.94M | -99K | 9.54M | 9.72M |
| Capital Expenditures | -441K | -272K | -27K | -492K | -1.29M | -2.6M | -1.07M | -705K | -6.2M | -1.59M | -602K | -64K | 0 | -12K | -130K | -211K | -436K | -99K | -455K | -278K |
| CapEx % of Revenue | - | - | 34.62% | 51.95% | 285.84% | 870.81% | 97.73% | -92.89% | 1601.81% | 4.75% | 10.31% | 0.77% | - | 0.23% | 2.19% | 1.26% | 2.11% | 0.25% | 1.34% | 0.93% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 351K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.56M | 34.67M | 15.67M | -52K | -38K | 60K | -8.03M | 783K | 124.49M | 120K | 43.03M | 14.08M | -24.79M | -2.59M | 149K | 0 | 612K | 36.88M | 1.73M | 21.16M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.56M | -15.67M | 15.67M | 50K | 5K | 85K | -271K | 849K | 56K | 120K | 40M | 0 | 0 | 0 | 0 | 0 | 415K | 36.88M | 1.69M | 21.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 50.34M | 0 | -102K | -43K | -25K | -7.75M | -66K | 124.44M | 0 | 3.03M | 14.08M | 82K | -2.59M | 149K | 0 | 197K | 0 | 38K | 104K |
| Net Change in Cash | -24.63M | 13.75M | -6.5M | -18.25M | -16.94M | -20.04M | -32.18M | -6.59M | 131.97M | -15.9M | 26.51M | -2.69M | -34.02M | -12.52M | 19.49M | -6.41M | -24.99M | 24.62M | -620K | -588K |
| Free Cash Flow | -28.17M | -20.9M | -22.16M | -18.2M | -16.89M | -20.12M | -24.18M | -7.71M | 7.49M | -16.03M | -16.52M | -23.35M | -9.21M | -9.91M | -8.89M | -12.06M | 3.92M | -12.37M | -12.32M | -31.74M |
| FCF Margin % | - | - | -28412.82% | -1922.28% | -3737.17% | -6750.34% | -2198.45% | 1015.41% | 1935.92% | -47.94% | -282.86% | -282.48% | -140.67% | -188.74% | -149.8% | -71.81% | 18.91% | -31.5% | -36.23% | -106.02% |
| FCF Growth % | -66.78% | -3.89% | 8.36% | -136.2% | -325.47% | -25.47% | -46.4% | 66.99% | 181.3% | -61.84% | -85.71% | -93.62% | -335.26% | 19.91% | 27.79% | 62% | 135.9% | -85.71% | -1.32% | -326.59% |
| FCF per Share | -0.93 | -0.70 | -0.83 | -0.70 | -0.65 | -0.76 | -0.93 | -0.30 | 0.35 | -0.90 | -3.05 | -4.52 | -1.79 | -1.94 | -1.74 | -2.50 | 0.77 | -2.50 | -2.97 | -8.27 |
| FCF Conversion (FCF/Net Income) | 2.42x | -1.50x | 0.56x | 0.19x | 0.43x | -1.10x | 1.30x | 0.68x | -0.57x | -1.04x | 0.28x | 0.13x | 1.02x | 0.87x | 0.40x | -2.01x | -0.55x | -1.43x | -0.41x | -2.57x |
| Interest Paid | 1.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 611K | 0 | 625K | 632K | 602K | 520K | 494K | 499K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |